Filters

Clear all

Expert Opinion

Plain Language Summary

Expert Review

Clinical Imbalances

Immune and inflammation

Gastro-intestinal

Structural Integrity and Musculoskeletal

Modifiable Lifestyle Factors

Diet

Laboratory Testing

Blood

Stool

Imaging

Text Availability

Abstract

342

Full text

246

Free full text

Publication Types

Journal Article

353

Randomized Controlled Trial

149

Review

126

Research Support, Non-U.S. Gov't

120

Clinical Trial

Comparative Study

Multicenter Study

Systematic Review

Meta-Analysis

Research Support, U.S. Gov't, P.H.S.

Controlled Clinical Trial

Research Support, N.I.H., Extramural

Letter

Case Reports

Observational Study

Research Support, U.S. Gov't, Non-P.H.S.

Clinical Trial, Phase II

Comment

Consensus Development Conference

Clinical Trial, Phase I

Guideline

Historical Article

Clinical Trial Protocol

Editorial

Publication Year

From

Quick links

Individual year

2026

2025

2024

2023

2022

2021

2020

2019

2018

2017

2016

2015

2014

2013

2012

2011

2010

2009

2008

2007

2006

2005

2004

2003

2002

2001

2000

Sort by:

selected

Print page

Email selected articles

Favourite selected articles

Create a NED Search Alert for this search

Save this search

Advanced Search

Run an advanced search

Results for
""Orlistat""[mesh_terms]

358 Results

Searching titles within these results

Spotlight on orlistat in the management of patients with obesity.

Monique P Curran, Lesley J Scott

Treatments in endocrinology 2005;4(2):127-9

Full Text

Abstract

Comprehensive Review of Current and Upcoming Anti-Obesity Drugs.

Sungrae Kim, Jang Won Son

Diabetes & metabolism journal 2021;44(6):802-818

Free Full Text

Abstract

Obesity and pharmacologic therapy.

Louis J Aronne, Marie Thearle

Endocrinology and metabolism clinics of North America 2004;32(4):1005-24

Full Text

Abstract

Role of pancreatic lipase inhibition in obesity treatment: mechanisms and challenges towards current insights and future directions.

Vetriselvan Subramaniyan, Yusoff Umul Hanim

International journal of obesity (2005) 2025;49(3):492-506

Free Full Text

Abstract

Successful Treatment of Cirrhotic Chylous Ascites using Orlistat and Dietary Modifications: A Case Study and Literature Review.

Yazan Nofal, Sara Mahmoud, Safa Al-Rawi, Ali Rahil

The American journal of case reports 2023;24():e938611

Free Full Text

Abstract

What are the risks and the benefits of current and emerging weight-loss medications?

Jamie R Robinson, Kevin D Niswender

Current diabetes reports 2010;9(5):368-75

Full Text

Abstract

Pharmacologic agents for the treatment of obesity.

Monica Mathys

Clinics in geriatric medicine 2005;21(4):735-46, vii

Full Text

Abstract

Orlistat-associated adverse effects and drug interactions: a critical review.

Dimitri P Mikhailidis, Christos S Derdemezis, Moses S Elisaf, Irene F Gazi, Eleni S Nakou, Theodosios D Filippatos

Drug safety 2008;31(1):53-65

Full Text

Abstract

Orlistat and calcium oxalate crystalluria: an association that needs consideration.

Mohamed H Ahmed

Renal failure 2011;32(8):1019-21

Free Full Text

Abstract

Orlistat in the treatment of obesity.

Priscilla Hollander

Primary care 2003;30(2):427-40

Full Text

Abstract

Orlistat in the treatment of obesity.

A Ballinger

Expert opinion on pharmacotherapy 2001;1(4):841-7

Full Text

Abstract

Obesity.

David Arterburn

Clinical evidence 2005

Full Text

Effect of Orlistat on anthropometrics and metabolic indices in children and adolescents: a systematic review and meta-analysis.

Zeinab Nikniaz, Leila Nikniaz, Mahdieh Abbasalizad Farhangi, Hossein Mehralizadeh, Shabnam Salekzamani

BMC endocrine disorders 2023;23(1):142

Free Full Text

Abstract

Short-term orlistat therapy improves fatty infiltration indices and liver fibrosis scores in patients with non-alcoholic fatty liver disease and metabolic syndrome.

Vian Ahmed Wasta Esmail, Marwan S M Al-Nimer, Mohammed Omer Mohammed

Arab journal of gastroenterology : the official publication of the Pan-Arab Association of Gastroenterology 2021;22(1):1-5

Full Text

Abstract

Treatment of obesity and metabolic-associated fatty liver disease with a diet or orlistat: A randomized controlled trial.

Congxiang Shao, Xiongcai Feng, Yansong Lin, Shuyu Zhuo, Zhi Dong, Junzhao Ye, Bihui Zhong

The American journal of clinical nutrition 2023;117(4):691-700

Plain Language Summary

Free Full Text

Abstract

Results: 1 – 15 / 358

Filters

Expert Opinion

Clinical Imbalances

Modifiable Lifestyle Factors

Laboratory Testing

Text Availability

Publication Types

Publication Year

Results for ""Orlistat""[mesh_terms]

Spotlight on orlistat in the management of patients with obesity.

Comprehensive Review of Current and Upcoming Anti-Obesity Drugs.

Obesity and pharmacologic therapy.

Role of pancreatic lipase inhibition in obesity treatment: mechanisms and challenges towards current insights and future directions.

Successful Treatment of Cirrhotic Chylous Ascites using Orlistat and Dietary Modifications: A Case Study and Literature Review.

What are the risks and the benefits of current and emerging weight-loss medications?

Pharmacologic agents for the treatment of obesity.

Orlistat-associated adverse effects and drug interactions: a critical review.

Orlistat and calcium oxalate crystalluria: an association that needs consideration.

Orlistat in the treatment of obesity.

Orlistat in the treatment of obesity.

Obesity.

Effect of Orlistat on anthropometrics and metabolic indices in children and adolescents: a systematic review and meta-analysis.

Short-term orlistat therapy improves fatty infiltration indices and liver fibrosis scores in patients with non-alcoholic fatty liver disease and metabolic syndrome.

Treatment of obesity and metabolic-associated fatty liver disease with a diet or orlistat: A randomized controlled trial.

Results for
""Orlistat""[mesh_terms]